Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,670.00    40.00 (0.71%)
Bid:
5,660.00
Ask:
5,680.00
Spread: 20.00 (0.353%)
Market Cap: £3.04b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director/PDMR Shareholding

30 Mar 2017 10:48

RNS Number : 0242B
Cranswick PLC
30 March 2017
Β 

AnnexΒ DTR3

Β 

Notification ofΒ TransactionsΒ ofΒ Directors/PersonsΒ Discharging

Managerial ResponsibilityΒ andΒ Connected Persons

Β 

PleaseΒ completeΒ allΒ relevantΒ boxesΒ shouldΒ in blockΒ capitalΒ letters.

Β 

1.

Β 

Name of the issuer

Β 

Cranswick plc

Β 

2.

Β 

State whether the notification relates to (i) a transaction notified in accordance with DTR

3.1.2 R, (ii) a disclosure made in accordance with section 793 of the Companies Act 2006, or (iii) in accordance with paragraph 26 of the Model Code

Β 

Β All 3 sections

Β 

Β 

3.

Β 

Name of person discharging managerial responsibilities/director

Β 

John Mark Bottomley

Β 

4.

Β 

State whether notification relates to a

person connected with a person discharging managerial responsibilities/director named

in 3 and identify the connected person

Β 

Β 

Β 

5.

Β 

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest1

Β 

3

Β 

6.

Β 

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

Ordinary 10p Shares

Β 

7.

Β 

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

Mark Bottomley - 4,090

Β 

Β 

8

Β 

State the nature of the transaction

Β 

Β 

Save As You Earn Options

Β 

9.

Β 

Number of shares, debentures or financial instruments relating to shares acquired

Β 

2,590 Ordinary shares

Β 

10.

Β 

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

Β 

0.0051%

Β 

11.

Β 

Number of shares, debentures or financial instruments relating to shares disposed

Β 

12.

Β 

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

Β 

13.

Β 

Price per share or value of transaction

Β 

579p

Β 

14.

Β 

Date and place of transaction

Β 

28.03.2017

Β 

Β 

15.

Β 

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 69,590 (0.1379%)

Β 

Β 

Β 

Β 

Β 

16.

Β 

Date issuer informed of transaction

Β 

28.03.2017

Β 

If aΒ personΒ discharging managerialΒ responsibilitiesΒ hasΒ been granted options byΒ theΒ issuer complete the following boxes

Β 

Β 

17

Β 

Date of grant

Β 

18.

Β 

Period during which or date on which exercisable

Β 

19.

Β 

Total amount paid (if any) for grant of the option

Β 

20.

Β 

Description of shares or debentures involved (class and number)

Β 

21.

Β 

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

Β 

22.

Β 

Total number of shares or debentures over which options held following notification

Β 

23.

Β 

Any additional information

Β 

24.

Β 

Name of contact and telephone number for queries

Β 

Β 

Β 

NameΒ ofΒ authorisedΒ officerΒ ofΒ issuerΒ responsibleΒ forΒ makingΒ notification

Β 

Β 

Malcolm Windeatt

Β 

Date ofΒ notificationΒ 30.03.2017

Β 

Β 

Β 

ThisΒ formΒ is intendedΒ forΒ useΒ byΒ anΒ issuerΒ toΒ makeΒ aΒ RISΒ notificationΒ requiredΒ byΒ DRΒ 3.1.4R (1).

Β 

Β 

(1) An issuerΒ makingΒ aΒ notificationΒ inΒ respectΒ of aΒ transactionΒ relatingΒ toΒ theΒ sharesΒ or debentures ofΒ theΒ issuerΒ shouldΒ completeΒ boxesΒ 1 toΒ 16,Β 23Β andΒ 24.

Β 

(2) An issuerΒ makingΒ aΒ notificationΒ inΒ respectΒ of aΒ derivativeΒ relatingΒ theΒ sharesΒ ofΒ theΒ issuer shouldΒ completeΒ boxesΒ 1Β to 4,Β 6,Β 8,Β 13,Β 14,Β 16,Β 23Β andΒ 24.

Β 

(3) An issuerΒ makingΒ aΒ notificationΒ inΒ respectΒ of optionsΒ grantedΒ toΒ aΒ director/personΒ discharging managerialΒ responsibilitiesΒ shouldΒ completeΒ boxesΒ 1Β to 3Β andΒ 17Β toΒ 24.

Β 

(4) An issuerΒ makingΒ aΒ notificationΒ inΒ respectΒ of aΒ financialΒ instrumentΒ relatingΒ toΒ theΒ sharesΒ ofΒ the issuerΒ (otherΒ thanΒ a debenture)Β shouldΒ completeΒ boxesΒ 1Β toΒ 4,Β 6,Β 8,Β 9,Β 11,Β 13,Β 14,Β 16,Β 23Β and

24.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHEANDEDLKXEEF
Date   Source Headline
2nd Jan 20243:05 pmRNSTotal Voting Rights
5th Dec 20232:25 pmRNSDirector/PDMR Shareholding
1st Dec 20231:34 pmRNSDirector/PDMR Shareholding
29th Nov 20239:18 amRNSIssue of Equity
21st Nov 20237:00 amRNSInterim Results
1st Nov 20233:21 pmRNSTotal Voting Rights
30th Oct 20239:09 amRNSHolding(s) in Company
5th Oct 202312:18 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:15 pmRNSBLOCK LISTING SIX MONTHLY RETURN
5th Oct 202312:10 pmRNSTotal Voting Rights
12th Sep 20232:06 pmRNSDirector/PDMR Shareholding
12th Sep 20232:05 pmRNSDirector/PDMR Shareholding
12th Sep 20232:03 pmRNSDirector/PDMR Shareholding
12th Sep 20232:02 pmRNSDirector/PDMR Shareholding
4th Sep 202310:30 amRNSTotal Voting Rights
29th Aug 20231:58 pmRNSDirectorate Change
29th Aug 202310:56 amRNSDirector/PDMR Shareholding
1st Aug 202312:16 pmRNSTotal Voting Rights
24th Jul 20235:56 pmRNSResult of AGM
24th Jul 20237:00 amRNSFirst quarter trading statement
3rd Jul 20232:04 pmRNSTotal Voting Rights
3rd Jul 20232:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:57 pmRNSDirector/PDMR Shareholding
3rd Jul 20231:56 pmRNSDirector/PDMR Shareholding
14th Jun 20238:21 amRNSHolding(s) in Company
5th Jun 20235:18 pmRNSTotal Voting Rights
1st Jun 20234:08 pmRNSDirector/PDMR Shareholding
23rd May 20237:01 amRNSDirector Appointment and Board Changes
23rd May 20237:00 amRNSPRELIMINARY RESULTS
2nd May 202312:56 pmRNSTotal Voting Rights
19th Apr 20232:44 pmRNSBlock listing Interim Review
19th Apr 20232:43 pmRNSBlock listing Interim Review
5th Apr 20239:00 amRNSAdditional Listing
4th Apr 20239:30 amRNSTotal Voting Rights
22nd Mar 20237:30 amRNSDirectorate Change
20th Mar 20231:38 pmRNSHolding(s) in Company
6th Feb 202310:00 amRNSTotal Voting Rights
2nd Feb 20237:00 amRNSThird quarter trading statement
23rd Jan 20239:30 amRNSAdditional Listing
18th Jan 202312:25 pmRNSTotal Voting Rights
6th Jan 202310:57 amRNSDirector/PDMR Shareholding
3rd Jan 202311:43 amRNSDirector/PDMR Shareholding
22nd Dec 202211:20 amRNSCranswick Scrip Dividend Scheme
2nd Dec 20225:47 pmRNSHolding(s) in Company
2nd Dec 20225:07 pmRNSHolding(s) in Company
29th Nov 20227:30 amRNSDirectorship
25th Nov 20221:48 pmRNSHolding(s) in Company
23rd Nov 20223:09 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSInterim Results
16th Nov 20223:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.